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Issues in Medical Devices
Ting-Wei Wang and Ting-Tse Lin
Abstract
Electromagnetic compatibility (EMC) in biomedical applications is a significant
issue related to the user's life safety, especially in implantable medical devices.
Cardiovascular diseases and neurodegenerative disorders are the main chronic dis-
ease worldwide that rely on implantable treatment devices such as cardiac pace-
makers and vagus nerve stimulators. Both devices must have high EMC to avoid
electromagnetic interference-induced health risks, even death during the treatment.
Thus, it is important to understand how EMI can affect implantable devices and
proactively protect devices from electromagnetic interference, providing reliable
and safe implantable device therapy. To this end, this chapter comprehensively
introduces the clinical issues and provides EMC requirements for the implantable
device such as a cardiac pacemaker and vagus nerve stimulator. The significance of
this chapter is to present the EMC important issues in medical engineering that can
help to evolve reliable and secure implantable device development in the future.
Keywords: Cardiac pacemaker, Cardiovascular disease, Electromagnetic
compatibility, Implantable device, Medical device, Neuroscience, Vagus nerve
stimulator
1. Physiological background for implantable medical device
1.1 Cardiac pacemaker
Cardiovascular diseases (CVDs) are the major cause of death globally, which
takes an estimated 17.9 million lives per year based on the World Health Organiza-
tion (WHO) statistics. Especially, arrhythmia has a strong clinical correlation with
sudden cardiac death (SCD) [1]. The irregular heart rhythm called arrhythmia can
mainly be divided into two main types: tachycardia arrhythmia and bradycardia
arrhythmia. As shown in Figure 1, the tachycardia and bradycardia arrhythmia
represent the heart beats too fast and slow, respectively. The physical treatment for
tachycardia and bradycardia syndrome required a regulator to suppress the abnor-
mal heart rhythm. The implantable cardiac pacemaker is commonly applied in the
cardiac modulation that generates the electrical stimulation pulse to regulate the
heart’s sinoatrial node, thus obtaining the normal rhythm.
As shown in Figure 2, the cardiac pacemaker would be activated once the heart
detector measures the abnormal cardiac rhythm. Thus, the stable operation of a
cardiac pacemaker is important for adverse patients, thus providing prompt treat-
ment in arrhythmia.
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1.2 Vagus nerve stimulator
Epilepsy is a neurological disorder that can induce the brain activities abnormal,
causing seizures and further loss of awareness suddenly [2–4]. According to WHO
statistics, epilepsy is a chronic non-communicable brain disease that affects humans
of all ages, around 50 million globally, becoming one of the most common neuro-
logical diseases worldwide. The risk in the death probability of epilepsy patients is
up to three times higher than healthy people. In epilepsy diagnosis, Electroenceph-
alogram (EEG) is the most common non-invasive approach to record the brain’s
electrical activity and identify the measured signals, whether it is epilepsy or not
[5]. In addition, the imaging-based diagnosis of computed tomography (CT) [6],
positron emission tomography (PET) [7], and MRI [8] can help further examining
brain-tumor-induced epilepsy. In epilepsy treatment, an vagus nerve stimulator is
the common physical approach implanted near the left chest area, as shown in
Figure 3. The electrode is attached around the vagus nerve in the neck to generates
the electrical pulses to the brain via the vagus nerve. The delay time more than
10 minutes from seizure onset would increase mortality, which emphasizes the
importance of timely treatment and time and medical emergency [9]. Therefore,
high reliability is crucial for vagus nerve stimulation (VNS) during incidental neu-
rological disease. Moreover, VNS is also widely applied in significant disease treat-
ment, including cardiac function [10], depression [11], anxiety [12], Parkinson’s
disease [13], and Alzheimer’s disease [14].
Figure 1.
Heart rhythm is divided into normal rhythm, tachycardia arrhythmia, and bradycardia arrhythmia.
Figure 2.
Schematic of the detection and treatment system for cardiac arrhythmia.
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Electromagnetic Compatibility
2. Electromagnetic interference for implantable medical device
The electromagnetic interference (EMI) in the implantable medical device can
be produced by the external source with the combined electric and magnetic fields
[10, 15], as shown in Figure 4. EMI is due to radiation that can be through the air
from many possible sources (Table 1) in our daily life [17–20], including the
Figure 3.
Schematic of vagus nerve stimulation and its installations.
Figure 4.
EMI in medical devices from external sources with time-varying electrical and magnetic fields such as base
station, radar, mobile device, and microwave oven [16].
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common consumer device such as mobile phones, radio frequency identification
(RFID) based systems, and microwaves. Moreover, the medical procedure-induced
EMI is a critical concern. For example, dental equipment and magnetic resonance
imaging (MRI) can generate EMI. In particular, the MRI equipment can cause a
strong EMI that is very hard to guard against. The MRI machine can produce an
intense magnetic field of about two or three teslas that are dangerous to any
electronic device. The electromagnetic susceptibility (EMS) is frequently used to
define immunity for EMI, which implies the degree of electronic system
malfunctions under varying levels of EMI. Therefore, electromagnetic compatibility
(EMC) in implantable medical devices such as cardiac pacemakers and vagus nerve
stimulators is important to sustain the stable and normal function to treat accidental
cardiac issues because humans are always surrounded by electrical equipment
[21, 22].
3. Electromagnetic compatibility for implantable medical device
3.1 EMI shield
The EMI shield is designed to decrease the electromagnetic (EM) wave transmis-
sion using a shield to increase the reflection or absorption of EM wave incident at the
interfaces between different mediums. As shown in Figure 5, the electric and mag-
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EMI sources from home, outdoor, medical, and industrial environments.
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propagation direction, which can be expressed as phasor form [23], according to
Eqs. (1) and (2).Where γ, α, β are the propagation, attenuation, phase constants of the







The EM wave propagates at the interface of two different mediums that induce
reflection due to impedance mismatching. The reflection coefficient (R12) and
transmission coefficient (T12) at the interface between two mediums can be deter-
mined, according to Eqs. (3) and (4). Ei, Er, η1, η2 represent incident, reflected
electric fields, impedances in Medium 1 and Medium 2, respectively. The imped-
ance in the medium can be defined by a ratio of electric field and magnetic field,
which is related to the permittivity (ε), permeability (μ), and conductivity (σ),
























The time-domain electric field can be rewritten as Eq. (6), according to Eq. (1).
E ¼ âyE0e
γz ¼ âyE0e
αz cos ωt βzð Þ (6)
When the EM wave propagates in the conductive shield (loss medium) at a time
of zero, the expression between the distance and amplitude of the electric field can
be obtained, according to (7).
E ¼ âyE0e
αz cos βzð Þ (7)
Figure 6 demonstrates the EM wave propagation in the conductive shield. The
skin depth (δ) can be defined as that penetration distance at which the intensity of
Figure 5.
Time-varying EM waves and the propagation, transmission, and reflection of the EM waves in different
mediums.
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the electric field attenuates to 1/e of the original incident wave intensity. According
to the Eqs. (8) and (9), the skin depth (δ) is the reciprocal of attenuation constant
(α), which is related to the EM operating frequency, permeability (μ), and conduc-













Thus, conductivity and permeability in shielding design play an important role
in EM wave absorption enhancement, thus increasing the overall EMI shielding
effectiveness.
However, the implantable medical device is not a fully closed system that must
require the openings of the shield to interact with external equipment such as body
sensing devices for signal transmit or receive. In some cases, the external controlled
magnetic fields or electrical signals can be utilized to externally modulate the
stimulation protocol of implantable medical devices according to patients’ clinical
requirements. So, the selective filtering of EMI waves is important for implantable
medical devices to classify the noise and external signals. Thus, the EMI filter was
provided in the following subsection to promote the EMC applications in implant-
able medical devices.
3.2 EMI filter
The filter implementation is also a strategy for EMI elimination in medical
devices [24–27]. For example, the typical ranges of P, R, T waves in ECG are 20 to
40 Hz, 18 to 50 Hz, and 0 to 10 Hz [28], as shown in Table 2.
Filtering can be divided into active and passive modes. Active filters consist of
several operational amplifiers and passive elements such as capacitors and resistors.
[29–32]. The active filters are applied in wide applications owing to excellent filter
performance. However, the active filters need a power source to sustain the
Figure 6.
Schematic of skin depth of EM waves using the shield.
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operations. Moreover, the upper frequency of active filters may be limited. Thus,
the active filter is not suitable for EMI filtering in implantable medical devices. The
active filter can perform programmatical filtering for the received signals, thus
separating the signal from noise. However, programmatical computation requires a
high-cost and complex circuit with larger power consumption to sustain the
processing functions. Because the implantable devices aim to sustain life, such
devices are not expected to remove or insert frequently because of extremely high
costs for device failure.
Moreover, it is not easy to replace it if the devices fail due to the high risk of
surgery. The concern regarding the surgery risk, which makes battery life issues
more important. Owing to the battery requirements of implantable medical devices,
the minimization of filters’ power is crucial to prolong the implantable device
lifespan.
The capacitor-based passive filter is frequently used for most high-frequency
noise in the surrounding ambient for the filter design regarding implantable medi-
cal devices. Capacitors can filter EMI noise utilizing absorption and smoothing of
electromagnetic noise. The high-frequency noise attenuates as quickly as charging
and discharging the capacitor-based filter. Absorbing such EMI noise to the ground
will neutralize or prevent specific frequencies from passing through the circuit, as
shown in Figure 7.
The discoidal capacitor and feedthrough capacitor array were commonly utilized
in the practical applications of medical devices, which deliver high-density perfor-
mance with low-volume packaging [33–35], as shown in Figure 8.
The circular-shaped discoidal capacitor is one of the most common constructions
for feed-through-style EMI filters. Circular capacitors outside and inside diameters
serve as connection points for the case and the lead and serve as the capacitor poles.
Moreover, several discoidal capacitors can be assembled to integrate as a capacitor
array on a single piece of ceramic [36]. Such assembly offers the highest filter
performance within the limited physical dimension. Thus, the feedthrough




Muscle signals 30–200 3.5
Table 2.
Significant frequency bandwidth of ECG waveform [28].
Figure 7.
Filter implementation for removing the time-varying electric and magnetic fields.
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capacitor array provides the merits of the miniature dimension and lightweight
within a high-density implantable device [37].
However, a feedthrough filter will have a double impact on battery life. First, a
minimal amount of current always flows between the plates of the charging capac-
itor. Since one capacitor is processing the signal and the other capacitor is grounded,
the leakage current will drain the battery over time. A strong dielectric with an
appropriate thickness can resist this current flow, thereby significantly reducing
battery consumption. Besides, filter design in implantable medical devices is to
minimize the loss of expected signals. The filter’s insertion loss implies how much a
signal will be lost or reduced for each frequency. An excellent filter requires a lower
insertion loss for signal frequencies and a higher insertion loss for noise frequencies.
Some energy in the expected signal will attenuate in internal resistance and induc-
tance of the filter, which implies that the implantable battery needs optimize in the
power design. Thus, an optimized design can suppress the energy loss. The less
power dissipated in the battery, which extends battery life and improves
effectiveness.
4. Conclusion
This chapter has demonstrated the EMC methodology for implantable medical
devices. A common effective EMI removal approach was provided by EMI shielding
and filtering. Such EMC design in implantable medical devices can resist EMI day-
to-day exposure to ensure the stable and reliable operation in implantable medical
devices such as cardiac pacemakers and vagus nerve stimulators.
Figure 8.
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